Medicinova (MNOV) Tax Provisions (2010 - 2018)
Medicinova (MNOV) posted quarterly Tax Provisions of $1706.0 for Q4 2018, up 100.1% year-over-year from $852.58 in Q4 2017, and up 2.59% quarter-over-quarter from $1663.0 in Q3 2018.
Medicinova (MNOV) Tax Provisions (2010 - 2018) Analysis & Trends
Medicinova (MNOV) has reported Tax Provisions for 9 consecutive years, with $1706.0 the latest figure, recorded in Q4 2018.
- In Q4 2018, Tax Provisions rose 100.1% year-over-year to $1706.0; the TTM figure through Dec 2018 stood at -$1.7 million (changed 0.16% YoY), while the FY2025 annual figure was -$2.5 million, down 354.72% from the prior year.
- Tax Provisions improved to $1706.0 in Q4 2018 per MNOV's latest filing, from $1663.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $4060.0 in Q1 2017 and bottomed at -$1.8 million in Q4 2017.
- Historically, Tax Provisions has averaged -$91138.6 across 5 years, with a median of $1547.0 in 2014.
- Annual changes were most pronounced in 2014 — Tax Provisions jumped 223.94% — and 2017, when it plunged 400859.73%.
- Medicinova's Tax Provisions stood at -$8534.0 in 2014, then soared by 116.04% to $1369.0 in 2015, then plunged by 131.92% to -$437.0 in 2016, then slumped by 400859.73% to -$1.8 million in 2017, then soared by 100.1% to $1706.0 in 2018.
- Business Quant data shows MNOV's Tax Provisions at $1706.0 in Q4 2018, $1663.0 in Q3 2018, and $1907.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Medicinova | 68.42 Mn | 68.42 Mn | 317,759.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 1,706.00 |
| Sep 30, 2018 | 1,663.00 |
| Jun 30, 2018 | 1,907.00 |
| Dec 31, 2017 | -1.75 Mn |
| Sep 30, 2017 | 2,054.00 |
| Jun 30, 2017 | 2,030.00 |
| Mar 31, 2017 | 4,060.00 |
| Dec 31, 2016 | -437.00 |
| Sep 30, 2016 | 1,675.00 |
| Jun 30, 2016 | 1,011.00 |
| Mar 31, 2016 | 1,505.00 |
| Dec 31, 2015 | 1,369.00 |
| Sep 30, 2015 | 1,383.00 |
| Jun 30, 2015 | 1,661.00 |
| Mar 31, 2015 | 2,946.00 |
| Dec 31, 2014 | -8,534.00 |
| Sep 30, 2014 | 1,472.00 |
| Jun 30, 2014 | 1,547.00 |
| Mar 31, 2014 | 1,543.00 |
| Dec 31, 2013 | 1,685.00 |